Member Info for Natdan

Bakky, I visited the original NIPT building once, a dated non-descript unit on a science-park, it's only saving grace being a traditional ale house not a 100 yards from the front door.
The new HQ is less than half a mile from this on Nelson street. I haven't seen it, but it is right on the doorstep of Manchester's largest hospital ( including maternity units) and includes the rich catchment area of the brains of University of Manchester, loosely incorporated in the Northern Powerhouse area. Location for a booming High-tech diagnostic firm? Brilliant . Size and facilities to accommodate expansion? Sorry have no idea.

My one and only present concern is the Illumina platform endorsement which is awaited. Although am sure the necessary paperwork would have been meticulously and professionally submitted , what chance some bureaucrat sitting on the application under the guise of lockdown/virus/Brexit or any other excuse, causing unnecessary commercial delays?

Closetrader, 'Follow the money' is a laudable rule to pursue, but for us mere mortal PIs not an easy one to achieve with any degree of consistency or certainty.
A more accurate rule of thumb is that the closer an investor can get to the money, the more likely it is to turn a profit. That may explain why most of us PIs are excluded from the select table and have to make a value judgment call on whatever info. Is available.

Agree pacman1- the future is bright, the future is....
Do believe LR has played a master stroke here by deliberately not lining up all the ducks at the same time in the same barrel.
The primary function of the trading update is fulfilled and positive in the sense of the core business is in good health.
The future revenue growth bombs can and will be pronounced upon in the coming weeks and months - Illumina platform,NCYT and NHS bonus side lines will keep investors salivating.
The SP now has a strong base for goodies to come along and build upon.

Oh Twix! Having been ridiculed to silence on the other site, why do you continue the drivel of negativity, to the extent of still clearly being traumatised by the V...days?
Ygen is a completely different beast to the company it was born from, positioned in fast-growing markets and with dynamic management. With the added potential of enhanced earnings from the virus diversion.
Still baffles me why you still here, the pretend sage of forward-predictions. Not.

Just wanted to note my appreciation of the quality of research feeding through on this site in recent times, great to read the quality of understanding and digging beneath the surface from a number of our regular posters.
Keep up the great work, it's way above my capability am ready to admit!

On a personal note, it is weird to note that I spent nearly 30 years of my working life in the proximity of Nelson Street, Manchester, and here's me now fully expecting a Brucie bonus payback emanating from YGEN's very own HQ.
Now that WOULD be good karma!

Yes, a degree of amusement with the panic-posters traumatised by a minimal drop, immediately ratcheted back up by plenty of buyers.
These short-terners clearly didn't live through the litigation days...

He will be busy at the coal-face doing the deal(s), hopefully.

Think any delay in onwards and upwards may be due to YGEN's place in the distribution chain:
Novacyt has the complete kit and so is banging out the orders, the profit one assumes goes straight to their bottom line.
YGEN's last RNS showed it being able to offer key components for the kit, hence at best it is presently a sub contractor, with ambitions short-term to be a supplier of tests itself .
There is also the NHS link it is seeking. Not to forget the core business ongoing.
Update news is eagerly awaited but until it arrives a degree of uncertainty probably puts a brake on any SP upward momentum.
I have confidence in Mr Rees and his pedigree and, like John Lewis, an opportunity like this will not be knowingly undersold.

Punit, only you can make that decision.
What I would say is it seems it took the market approx 4 weeks to wake up to Novacyt's breakthrough, the SP has gone stratospheric since.
What is especially noteworthy in LR's RNS is that he reassures that YGEN can not only ramp up production to meet the new business opportunity, but this will not impact the core business which continues to earn.
Surely this can only be massively revenue- generative.
DYOR

Seems to be that Novacyt (British company) has gained emergency FDA approval in the US to churn out diagnostic kits re Coronavirus testing.
Ygen, also being a molecular diagnostic company, has been sub-contracted to help meet the demand.
Big-bucks all round one would expect, once the market properly cottons on...

Down from 17p to below 15p in less than a week hardly makes safe-haven territory!

A RNS for the benefit of Twix, hopefully this will sooth his fears.
The application for approval continues apace towards its logical conclusion. Whether it happens in q1 or (more likely) into q2, the building bricks are in place and as LR emphasises, the approval will provide serious momentum growth.

Yes Steve67, what a difference a Midas Tip of the Year makes! The momentum is most certainly building nicely, but it seems there may be a fair number of PIs from the early days still seeking to exit on a break-even or modest profit on the way up to the 20p level or even beyond.
Not necessarily a bad thing as new buyers (hopefully IIs as well) attracted by the firm foundations now in place coupled with rapid organic growth, should ensure a firm upward trend.

Am a little suspicious as to the number of trades with this Plc which are entered, only to be "cancelled" some hours later.
Today, for example, we had two substantial trades at 10.45am, one of 500k and one of 250k, both being shown as "sells", only to be voided late in the trading day.
It is difficult to continually put such errors down to "fat-finger syndrome" in the form of typo errors.
Such significant trades, I do believe, could influence the direction of travel of a SP at any given moment.
Is this simply a computer playing algorithmic games, or am I being paranoid if I was to think this could be market manipulation in some way?

Thanks Linton, the truth is I've never really been away, I tend to appear to counter the euphoria which invariably accompanies PF's more soothing updates. Drill into the detail and it amounts to so much gloss, bit like a Christmas bauble full of glitter.

It is now clear that PF feels one of his tasks is to provide Festive cheer to long suffering investors here.
As reliable as Santa, but with a sack half empty. Flogging off the SQ (with free delivery) provides the ChrIstmas cracker joke, payable interest-free over 3 years..assuming of course the propeller stays on and the rust bucket stays afloat.
The Africa connection in my view increases risk not reduces it - generating income does not necessarily mean it is money in the bank, and the continued doing of business in the absence of a signed contract should cause anxiety.
The French connection update (a man in a shed you will recall) is meaningless.
Saudi provides PF with an opportunity for him to exercise his taste for name dropping, as if this particular Bin person should be accepted at face value.
I could go on ,but the £ 1 party is as far away as ever.
Merry Xmas to all PF's readers...

Notaflipper, how very dare you make such a suggestion!
I respect and find generally informative your posts here, but your recent negativity is perhaps a tad unwarranted given the progress made since LR's arrival.
I wonder if this is connected with your confessional in August where if you are to be believed, you largely exited left, pursued by a bear, at a price quite a bit lower than today's levels.
Perhaps it's not too late to jump back in, maybe take a punt ahead of the results, and with the Co's shiny new Manchester offices to boot!
Dyor as I am sure you always do

This obsession with "contracts" by certain contributors continues to ignore the far more important strategy the Co. now has.
If we were selling widgets per se as in the early NIPT days when a single product was all that was available to peddle, then yes a 'contract' secured provided at least a comfort blanket. Even though value, margins and ultimately profit were unknowns.

LR has effectively turned YGEN into a service-provider, whereby a much larger scope product is available, in individual countries. Once traction takes hold, potential growth is likely more rapid than the pedestrian selling of X number of widgets to Y hospital in isolation.
'Contracts' is for those of an insecure disposition who like the 'reassurance' and warmth it brings to the RNS table, but in a way that is nigh-on impossible to evaluate financially.
Note the recent re-booting of the sales staff to sell multi-product.
LR has said he intends to "sweat the assets" (I love that expression).
Would anyone bet against that , contract or no?

Twix, every forum has its resident bore and you have nicely filled that role since earliest NIPT days.
Am very satisfied with the company strategy, including only announcing any material contract wins above a specified valuation.
Such a pervader of negativity as you have amply demonstrated on a regular basis strongly indicates an individual who is unhappy to be here. So it beggars the question: are you really here at all?